Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Double-blinded, Active Controlled, Non-Inferiority, Multicenter, Phase IV Clinical Trial to Evaluate the Efficacy and Safety of Sto M Tab. in Patients With Acute or Chronic Gastritis

NCT07631065 is registered in ClinicalTrials.gov with Mather's Pharm. Co., Ltd. as lead sponsor.

NCT NCT07631065
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07631065 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Double-blinded, Active Controlled, Non-Inferiority, Multicenter, Phase IV Clinical Trial to Evaluate the Efficacy and Safety of Sto M Tab. in Patients With Acute or Chronic Gastritis
Lead sponsor
Mather's Pharm. Co., Ltd.
Phase
Phase 4
Overall status
Not yet recruiting
Start date
June 30, 2026
Completion date
February 29, 2028
Enrollment
470 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

acute gastritis, chronic gastritis, gastritis